Calibrate and Found are two prominent telehealth platforms offering GLP-1 receptor agonist programs for weight loss and metabolic health
Sikiric, P., Seiwerth, S., Rucman, R., Kolenc, D., Batelja Vuletic, L., Drmic, D., & Vlainic, J
Kennedy tore into Ozempic maker Novo Nordisk in a September 26 X post, saying he'd address a "sick food system" rather than "gladden the wallets of distant Big Pharma execs." (Novo's stock dropped more than 4% following the news of Kennedy's nomination.) Here's what his stances could mean for companies trying to tackle obesity in various ways, from lifestyle changes to medication
It increases intramuscular creatine stores, facilitates ATP production when needed most, and works with resistance training to prevent strength and mass from declining during a caloric deficit